Sequential Modification of NEMO/IKKγ by SUMO-1 and Ubiquitin Mediates NF-κB Activation by Genotoxic Stress

Cell

Volumn 115, Issue 5, 2003, Pages 565-576

  Huang, Tony T ^a   Wuerzberger Davis, Shelly M ^a   Wu, Zhao Hui ^a   Miyamoto, Shigeki ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SUMO 1 PROTEIN; UBIQUITIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; EMBRYO; ENZYME SUBUNIT; GENOTOXICITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN MODIFICATION; STRESS; UBIQUITINATION;

ANIMALIA;

EID: 0344305376     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00895-X     Document Type: Article

References (56)

1. Abraham R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15:2001;2177-2196.
2. Anest V., Hanson J.L., Cogswell P.C., Steinbrecher K.A., Strahl B.D., Baldwin A.S. A nucleosomal function for IκB kinase-a in NF-κB-dependent gene expression. Nature. 423:2003;659-663.
3. Baeuerle P.A., Baltimore D. Iκb. a specific inhibitor of the nf-κb transcription factor Science. 242:1988;540-546.
4. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 421:2003;499-506.
5. Brummelkamp T.R., Nijman S.M., Dirac A.M., Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature. 424:2003;797-801.
6. Criswell T., Leskov K., Miyamoto S., Luo G., Boothman D.A. Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation. Oncogene. 22:2003;5813-5827.
7. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., Slaughter C., Pickart C., Chen Z.J. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 103:2000;351-361.
8. Desterro J.M., Rodriguez M.S., Hay R.T. SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell. 2:1998;233-239.
9. Devary Y., Gottlieb R.A., Smeal T., Karin M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell. 71:1992;1081-1091.
10. Doffinger R., Smahi A., Bessia C., Geissmann F., Feinberg J., Durandy A., Bodemer C., Kenwrick S., Dupuis-Girod S., Blanche S.et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling. Nat. Genet. 27:2001;277-285.
11. Ghosh S., Karin M. Missing pieces in the NF-κB puzzle. Cell. 109(Suppl):2002;S81-S96.
12. Hietakangas V., Ahlskog J.K., Jakobsson A.M., Hellesuo M., Sahlberg N.M., Holmberg C.I., Mikhailov A., Palvimo J.J., Pirkkala L., Sistonen L. Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol. Cell. Biol. 23:2003;2953-2968.
13. Hoege C., Pfander B., Moldovan G.L., Pyrowolakis G., Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature. 419:2002;135-141.
14. Huang T.T., Miyamoto S. Postrepression activation of NF-κB requires the amino-terminal nuclear export signal specific to IκBα Mol. Cell. Biol. 21:2001;4737-4747.
15. Huang T.T., Wuerzberger-Davis S.M., Seufzer B.J., Shumway S.D., Kurama T., Boothman D.A., Miyamoto S. NF-κB activation by camptothecin. a linkage between nuclear DNA damage and cytoplasmic signaling events J. Biol. Chem. 275:2000;9501-9509. a.
16. Huang T.T., Kudo N., Yoshida M., Miyamoto S. A nuclear export signal in the N-terminal regulatory doman of IκBa controls cytoplasmic localization of the inactive NF-κB/IκBa complexes. Proc. Natl. Acad. Sci. USA. 97:2000;1014-1019. b.
17. Huang T.T., Feinberg S.L., Suryanarayanan S., Miyamoto S. The zinc finger domain of NEMO is selectively required for NF-κB activation by UV radiation and topoisomerase inhibitors. Mol. Cell. Biol. 22:2002;5813-5825.
18. Hunter T. Signaling-2000 and beyond. Cell. 100:2000;113-127.
19. Hur G.M., Lewis J., Yang Q., Lin Y., Nakano H., Nedospasov S., Liu Z.G. The death domain kinase RIP has an essential role in DNA damage-induced NF-κB activation. Genes Dev. 17:2003;873-882.
20. Jain A., Ma C.A., Liu S., Brown M., Cohen J., Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat. Immunol. 2:2001;223-228.
21. Karin M., Hunter T. Transcriptional control by protein phosphorylation. signal transmission from the cell surface to the nucleus Curr. Biol. 5:1995;747-757.
22. Karin M., Cao Y., Greten F.R., Li Z.W. NF-κB in cancer. from innocent bystander to major culprit Nat. Rev. Cancer. 2:2002;301-310.
23. Kastan M.B., Lim D.S. The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol. 1:2000;179-186.
24. Kovalenko A., Chable-Bessia C., Cantarella G., Israel A., Wallach D., Courtois G. The tumour suppressor CYLD negatively regulates NF-κB signaling by deubiquitination. Nature. 424:2003;801-805.
25. Kurepa J., Walker J.M., Smalle J., Gosink M.M., Davis S.J., Durham T.L., Sung D.Y., Vierstra R.D. The small ubiquitin-like modifier (SUMO) protein modification system in Arabidopsis. Accumulation of SUMO1 and -2 conjugates is increased by stress. J. Biol. Chem. 278:2003;6862-6872.
26. Li N., Karin M. Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms. Proc. Natl. Acad. Sci. USA. 95:1998;13012-13017.
27. Li Q., Verma I.M. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2:2002;725-734.
28. Li H., Kolluri S.K., Gu J., Dawson M.I., Cao X., Hobbs P.D., Lin B., Chen G., Lu J., Lin F.et al. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science. 289:2000;1159-1164.
29. Li N., Banin S., Ouyang H., Li G.C., Courtois G., Shiloh Y., Karin M., Rotman G. ATM is required for IκB kinase (IKK) activation in response to DNA double strand breaks. J. Biol. Chem. 276:2001;8898-8903.
30. Mahajan R., Delphin C., Guan T., Gerace L., Melchior F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell. 88:1997;97-107.
31. Mahanty S.K., Wang Y., Farley F.W., Elion E.A. Nuclear shuttling of yeast scaffold Ste5 is required for its recruitment to the plasma membrane and activation of the mating MAPK cascade. Cell. 98:1999;501-512.
32. Makris C., Roberts J.L., Karin M. The carboxyl-terminal region of IκB kinase gamma (IKKγ) is required for full IKK activation. Mol. Cell. Biol. 22:2002;6573-6581.
33. Malek S., Chen Y., Huxford T., Ghosh G. IκBβ, but not IκBα, functions as a classical cytoplasmic inhibitor of NF-κB dimers by masking both NF-κB nuclear localization sequences in resting cells. J. Biol. Chem. 276:2001;45225-45235.
34. Mao Y., Sun M., Desai S.D., Liu L.F. SUMO-1 conjugation to topoisomerase I. a possible repair response to topoisomerase-mediated DNA damage Proc. Natl. Acad. Sci. USA. 97:2000;4046-4051.
35. Matunis M.J., Coutavas E., Blobel G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135:1996;1457-1470.
36. May M.J., D'Acquisto F., Madge L.A., Glockner J., Pober J.S., Ghosh S. Selective inhibiton of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex. Science. 289:2000;1550-1554.
37. Miyamoto S., Seufzer B., Shumway S. Novel IκBα degradation process in WEHI231 murine immature B cells. Mol. Cell. Biol. 18:1998;19-29.
38. Muller S., Matunis M.J., Dejean A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17:1998;61-70.
39. Muller S., Hoege C., Pyrowolakis G., Jentsch S. SUMO, ubiquitin's mysterious cousin. Nat. Rev. Mol. Cell Biol. 2:2001;202-210.
40. Orth K., Xu Z., Mudgett M.B., Bao Z.Q., Palmer L.E., Bliska J.B., Mangel W.F., Staskawicz B., Dixon J.E. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science. 290:2000;1594-1597.
41. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70:2001;503-533.
42. Rodriguez M.S., Desterro J.M., Lain S., Midgley C.A., Lane D.P., Hay R.T. SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18:1999;6455-6461.
43. Rodriguez M.S., Dargemont C., Hay R.T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276:2001;12654-12659.
44. Ross S., Best J.L., Zon L.I., Gill G. SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol. Cell. 10:2002;831-842.
45. Rui H.L., Fan E., Zhou H.M., Xu Z., Zhang Y., Lin S.C. SUMO-1 modification of the C-terminal KVEKVD of Axin is required for JNK activation but has no effect on Wnt signaling. J. Biol. Chem. 277:2002;42981-42986.
46. Salghetti S.E., Caudy A.A., Chenoweth J.G., Tansey W.P. Regulation of transcriptional activation domain function by ubiquitin. Science. 293:2001;1651-1653.
47. Seeler J.S., Dejean A. Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell. Biol. 4:2003;690-699.
48. Smahi A., Courtois G., Vabres P., Yamaoka S., Heuertz S., Munnich A., Israel A., Heiss N.S., Klauck S.M., Kioschis P.et al. Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature. 405:2000;466-472.
49. Sun S.C., Ballard D.W. Persistent activation of NF-κB by the tax transforming protein of HTLV-1. hijacking cellular IκB kinases Oncogene. 18:1999;6948-6958.
50. Tam W.F., Sen R. IκB family members function by different mechanisms. J. Biol. Chem. 276:2001;7701-7704.
51. Tibbetts R.S., Cortez D., Brumbaugh K.M., Scully R., Livingston D., Elledge S.J., Abraham R.T. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14:2000;2989-3002.
52. Trompouki E., Hatzivassiliou E., Tsichritzis T., Farmer H., Ashworth A., Mosialos G. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature. 424:2003;793-796.
53. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 412:2001;346-351.
54. Weil R., Schwamborn K., Alcover A., Bessia C., Di Bartolo V., Israel A. Induction of the NF-κB cascade by recruitment of the scaffold molecule NEMO to the T-cell receptor. Immunity. 18:2003;13-26.
55. Yamamoto Y., Verma U.N., Prajapati S., Kwak Y.T., Gaynor R.B. Histone H3 phosphorylation by IKKα is critical for cytokine-induced gene expression. Nature. 423:2003;655-659.
56. Zhou B.B., Elledge S.J. The DNA damage response. putting checkpoints in perspective Nature. 408:2000;433-439.